Extended-release of Octreotide (LF-PB) for the Treatment of Lymphorrhea
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Lymphorrhea
Interventions: DRUG: LF-PB and Placebo|DRUG: Placebo|DRUG: LF-PB
Sponsor: Chemi S.p.A.